CALU and gastric cancer: The EMT pathway‐derived 5‐gene signature, namely CALU, PCOLCE2, PLOD2, SGCD, and THBS2, has a powerful prediction capacity for OS, facilitating patient stratification of GC patients with MSI‐H status.